CORD-19:932bcdd2f6c6d487386e8bf983e4874387771be1 / 911383-911555 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/932bcdd2f6c6d487386e8bf983e4874387771be1","sourcedb":"CORD-19","sourceid":"932bcdd2f6c6d487386e8bf983e4874387771be1","text":"Since the first description in 1999, there have been reports on 12 patients with anti-Ma (anti-PNMA1 and PNMA2) and 27 patients with anti-Ta reactivities (anti-PNMA2 only).","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T6317","span":{"begin":0,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T6317","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T12","span":{"begin":0,"end":172},"obj":"Sentence"}],"attributes":[{"subj":"T12","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#a6ec93","default":true},{"id":"CORD-19_Custom_license_subset","color":"#ec93c0"}]}]}}